ArticleTherapeutics and clinical risk management2019

Higher serum total bilirubin predicts high risk of 3-year adverse outcomes in patients undergoing primary percutaneous coronary intervention.

Fan Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.